Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 43)
31 March 2026
PPG showcases electrocoat and digital innovations at ECOAT 26
At ECOAT 26, new pretreatment and electrocoat technologies, digital paint‑shop tools and services to cut waste and costs, boost efficiency; exec keynote and interactive demo included.
31 March 2026
Covestro at Techtextil 2026: sustainable, productivity-focused textile solutions
Showcases coatings, adhesive films and TPUs: waterborne/partly bio-based PUs, antimicrobial finishes, high-performance TPU films for electronics/CIPP, recyclable cushioning and SCF-foamable TPUs
31 March 2026
Johnson Matthey DPFi DPF earns Canadian CSA certification
Electrically regenerating diesel particulate filter certified by CSA for Canadian underground mining/tunnelling; also certified by Canmet and VERT and approved by US MSHA.
31 March 2026
BASF launches biomass‑balanced Ultrason® P 3010 BMB PPSU
New Ultrason P 3010 BMB is ISCC‑PLUS certified, 20% biomass‑balanced PPSU (mass‑balance), matches standard grade in properties and certifications, drop‑in replacement made with green electricity.
31 March 2026
Gestamp signs 10-year renewable PPA with Iberdrola for 660,000 MWh
Supply of 100% renewable power (80% wind/20% solar) from 34 MW capacity at fixed competitive price; supports electrification and decarbonisation of the auto supply chain. Certificates of origin.
31 March 2026
Lilly to acquire Centessa Pharmaceuticals for OX2R sleep‑wake portfolio
$38/ADS cash + up to $9 CVR (max $47/sh); upfront equity ~$6.3B (CVR ~$1.5B). Lead OX2R agonist cleminorexton showed positive Phase 2a for narcolepsy and idiopathic hypersomnia. Close expected Q3
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
31 March 2026
Umicore opens Shanghai innovation center
New 3,600 sqm Shanghai innovation center, first corporate R&D outside Europe; focuses on fuel cells and recycling, expanding to catalysis for renewables, CO2 capture, H2, and local partnerships.
31 March 2026
Messer 2025 results: €4.5bn revenue, €1.4bn EBITDA, €747m investments
Stable 2025: margin held, net debt reduced, staff >12k. Investments in air-separation, on-site/CO2/cylinder plants, helium, decarbonization, R&D/digitalization. 2026 growth expected.
31 March 2026
Mitsubishi Gas Chemical to End Polycarbonate Production at Kashima Plant
Discontinuing Kashima polycarbonate plant in March 2028 (120k t/yr) due to weak margins and oversupply. Domestic supply to shift to overseas sites; employees prioritized; financial impact under review.
31 March 2026
Topsoe signs FEED deal with Hynfra for Jordan green ammonia
FEED underway for Jordan green ammonia: synthesis tech will convert green H2 to ammonia, avoiding >200,000 t CO2e/yr. FID expected 2027; plant to start 2030; exports planned.
31 March 2026
Mitsubishi Chemical transfers KMC MMA monomer stake in Taiwan to CPDC
Dissolve co-ownership of Taiwan MMA unit amid stronger Asian competition and Chinese capacity growth; consolidate production to competitive sites and pursue high-growth markets. Completion Aug 3, 2026.
31 March 2026
Sumisho Venture Partners launches ¥10 billion fund
Shifting to a fund structure to enable medium/long‑term, larger lead investments, deepen portfolio engagement and co‑creation, and pursue strategic and financial returns in digital, AI and deep tech
30 March 2026
Holcim acquires majority stake in Cementos Pacasmayo
Acquisition expands Peru footprint: target had 2025 sales $630M, 28% adj. EBITDA; 3 plants (~5Mtpa) and 28 ready-mix/precast sites. Deal ~7.1x EBITDA post $40M synergies; EPS accretive Y1, ROIC Y3.
30 March 2026
Golden Pass LNG (QatarEnergy/ExxonMobil) achieves first LNG production
First LNG produced from Train 1 of the 18 mtpa Sabine Pass project, enabling sustained liquefaction and paving way for first cargo and full exports beginning Q2 2026.
30 March 2026
PETRONAS Monitors Malaysia’s Fuel Supply
Fuel supply strained by West Asia crisis—~40% of crude via Strait of Hormuz; crude prices +40%, shipping and insurance up. Domestic demand exceeds supply; govt subsidises RON95/diesel; avoid hoarding.
30 March 2026
Dow’s Carbon Footprint Ledger wins 2026 CIO 100 Award
Recognized for enabling verifiable PCF certificates, optimizing low‑GHG production pathways, and integrating supply‑chain, sustainability and finance data to scale trusted low‑carbon product offerings.
30 March 2026
Merck enlicitide decanoate, an oral PCSK9 inhibitor, reduces LDL‑C more than guideline non‑statins at 8 weeks
Phase 3 CORALreef AddOn: enlicitide lowered LDL‑C 64.6% at 8 weeks; 78.2% achieved ≥50% reduction and LDL‑C <55 mg/dL; safety comparable to oral non‑statins; FDA CNPV awarded
30 March 2026
Siemens USA appoints Ann Fairchild President & CEO
Ann Fairchild, with 25+ years at the company, named permanent president & CEO of its U.S. unit; will oversee ~50,000 employees and $24B revenue, focusing on AI, infrastructure and reshoring.
30 March 2026
LKAB raises mineral resources by 900 million tonnes to 7.2 billion tonnes
Exploration added volume and confidence; reserves ~0.9 Gt. Resources grew mainly at Malmberget; Per Geijer hosts 2.2 Mt REO in situ and phosphorus. EU strategic status granted.
30 March 2026
Velocys and SuMo commission Fischer–Tropsch unit at Wednesbury for UK waste-to-SAF
FT unit at Wednesbury is online and stable, validating integration of gasification and FT for waste-to-SAF and supporting ClearSkies demonstration toward modular, scalable SAF production.
30 March 2026
BASF Pharma Solutions raises prices up to 20% for excipients and selected APIs
Price change for excipients and selected APIs to support reliable supply amid rising energy and raw-material costs. Effective immediately or per contracts; company will monitor and update.
30 March 2026
LANXESS hikes sulfur-based product prices 40%
Immediate average 40% price increase on sulfur-based products (sulfuric acid, oleum, sodium bisulfite) due to higher sulfur, logistics and energy costs; adjustment needed to secure supplies.
30 March 2026
Iberdrola awards €3.5bn contracts for Eastern Green Link 4 HVDC subsea interconnector
Contracts awarded for a 640 km HVDC subsea link (2,000 MW) between Scotland and England, supplying 1.5M+ homes; construction starts 2028, commissioning 2033; part of wider UK grid investment.
30 March 2026
TotalEnergies completes UK North Sea merger with NEO NEXT
Merger completed; combined group renamed; one party holds a 47.5% stake. It becomes the largest independent producer on the UK Continental Shelf, with 2026 output >250,000 boe/d.
30 March 2026
Itabus fleet adopts Enilive HVO
Entire 100-vehicle fleet runs on HVO made from waste, cutting CO2eq by 79.5%. In 2025 it logged 20M km, used over 3M L HVO (53% avg, 75% peak in Dec).
30 March 2026
UPM opens Adhesive Materials terminal near New Delhi
New slitting and distribution terminal near New Delhi to boost service in Northern and Eastern India with tailored inventory and short lead times; complements Mumbai terminal; operations start Q3 2026.
30 March 2026
UBE obtains food-contact approval for UBECycle recycled PE/PA films
Accredited migration testing plus RecyClass‑certified recycling (following Paulowsky acquisition) confirm regulatory compliance and open use of mechanically recycled PE/PA in regulated packaging.
30 March 2026
GSK's bepirovirsen accepted for regulatory review in China for chronic hepatitis B
China NMPA accepted NDA for bepirovirsen after Phase III B-Well trials showed significant functional cure rates in treated CHB patients; granted Breakthrough Therapy; acceptable safety.
30 March 2026
GSK’s Exdensur approved in China for severe eosinophilic asthma
First ultra-long-acting IL-5 biologic for eosinophilic severe asthma; twice-yearly dosing cut annual exacerbations by ~48–58% in SWIFT trials and lowered hospital/ED visits.
30 March 2026
Eneve acquires Nemon to enter Iberian market
Acquisition opens Iberian market, adds 30 specialists, supports 100+ suppliers, expands platform with software for billing, forecasting, market comms and trading; integration under way
← Previous
Next →